|Articles|May 1, 2001
- Pharmaceutical Executive-05-01-2001
- Volume 0
- Issue 0
Friends of Complexity
Author(s)Wayne Koberstein
Pharmaceutical executives should study their own scientists. They construct clever tools to explore convoluted phenomena. They are the true friends of complexity.
Advertisement
Articles in this issue
almost 25 years ago
Policy: Task Mastersalmost 25 years ago
Pharmacia's Carrie Cox: HBA Woman of the Yearalmost 25 years ago
Under Federal Firealmost 25 years ago
Task Force: Enter the Fixersalmost 25 years ago
The Next Y2Kalmost 25 years ago
Political ScienceNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
2
What Governance Resets Should Pharma Companies Take in Response to AI?
3
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
4
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
5